DNA demethylation refers to the passage of DNA demethylation enzymes, including TDG (thymine DNA glycosylase), TET1 (methylcytosine dioxygenase 1) and TET2 (methylcytosine dioxygenase 2), which are essential from a range of studies of DNA demethylation, such as inhibitor screening, enzyme kinetics, selectivity analysis and protein arrays. DNA demethylation Methylation can be passive or active, and it is associated with epigenetic reprogramming of genes and important disease mechanisms. In some tumor tissues, 5-hmC levels are lower than in normal tissues and its deletion is considered as a possible biomarker for the diagnosis of cancer. Thus, DNA demethylation studies may lead to important discoveries with implications for cancer treatment.
At Creative Enzymes, our DNA demethylase screening services are based on high quality and efficient chemiluminescence technology. In addition, we offer a large selection of DNA demethylases and substrates produced in-house to facilitate your epigenetic research.
We require a minimum of 1 μg of purified enzyme or cell lysate per assay. We recommend that samples be frozen at -80°C until shipment.
We provide our clients with detailed reports that include all experimental procedures and results obtained. The report includes a summary of the assay design, optimization, validation and data analysis.
At Creative Enzymes, our goal is to apply innovative technologies to DNA demethylase inhibitor screening service. We offer innovative, flexible and scalable solutions that can meet the needs of our customers. We strive to meet this challenge as a global company that places a high priority on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality. If you would like to know more about this service, please feel free to contact us.
We are here to answer any question you may have